Insulin therapy in type 2 diabetes.
Kazlauskaite
Rasa
R
Department of Medicine, Rush Medical College, Chicago, Illinois, USA.
Fogelfeld
Leon
L
D001786:Blood Glucose / Q000378:metabolism; D015190:Blood Glucose Self-Monitoring; D002626:Chemistry, Pharmaceutical; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000188:drug therapy* / Q000378:metabolism; D018450:Disease Progression; D004734:Energy Metabolism; D015444:Exercise; D005227:Fatty Acids / Q000378:metabolism; D005943:Gluconeogenesis / Q000187:drug effects / Q000502:physiology; D006442:Glycated Hemoglobin / Q000378:metabolism; D006801:Humans; D006949:Hyperlipidemias / Q000209:etiology / Q000517:prevention & control; D006973:Hypertension / Q000209:etiology / Q000517:prevention & control; D007004:Hypoglycemic Agents / Q000737:chemistry / Q000494:pharmacology / Q000627:therapeutic use*; D007328:Insulin / Q000737:chemistry / Q000494:pharmacology / Q000627:therapeutic use*; D007333:Insulin Resistance / Q000502:physiology; D008099:Liver / Q000187:drug effects / Q000378:metabolism; D009765:Obesity / Q000150:complications / Q000517:prevention & control; D018579:Patient Selection; D017410:Practice Guidelines as Topic
D001786:Blood Glucose; D005227:Fatty Acids; D006442:Glycated Hemoglobin; D007004:Hypoglycemic Agents; D007328:Insulin